MIR6724-2

Across TCGA pan-cancer cohorts, MIR6724-2 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR6724-2 data layer.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where higher MIR6724-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6724-2 expression acts as an unfavorable survival marker.

PRAD are the cancer types where MIR6724-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PRAD	DFS	Tertile	All	0.545	0.935	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR6724-2–PRAD (DFS)

Open the PRAD breakdown →